News and Trends 14 Dec 2022PhoreMost and ThinkCyte collaborate on AI-based drug discovery PhoreMost Ltd. and ThinkCyte K.K have announced a strategic research partnership aimed at advancing modern phenotypic drug screening using artificial… December 14, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email